ESCAPE: Understanding how moms’ diets affect peanut and egg allergy risk in infants
Official title: Expecting Mothers' Study of Consumption or Avoidance of Peanut and Egg (ESCAPE)
Funded at University of Rochester · NIH-11543416 · Data updated 2026-11-12
A study following pregnant and breastfeeding families to understand how early exposure to peanut and egg might influence allergy risk in babies.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Rochester NIH-funded |
| Lab location | 1 site (Rochester, United States) |
| Project start | September 1, 2023 |
| Project end | August 31, 2029 |
| Funding year | 2026 |
| Award (this year) | $698,000 |
| NIH project number | 3U01AI173032-03S1 |
| Project ID | NIH-11543416 on NIH RePORTER |
Who could benefit from this research
✓Could help
Families expecting a baby or with an infant, especially those with a history of allergies or asthma, may participate from birth through early childhood.
✕Less likely to help
Families without access to follow-up care or those unable to commit to long-term participation may receive less direct benefit.
What this research studies
This project looks at how early feeding decisions and maternal factors could shape a child’s risk of developing peanut or egg allergy. Researchers will enroll families and track infant exposure to peanut and egg, along with immune responses, over time. The goal is to identify windows of opportunity for prevention so families can make informed choices and clinicians can tailor guidance for high-risk infants.
Why it matters
Potential benefit: findings could lead to better early-life strategies to reduce peanut and egg allergies in children.
How similar studies have gone: Previous trials suggest early introduction can reduce risk for some infants, but timing and population specifics remain unclear.
Where this research is happening
-
University of Rochester
Rochester, United States Active
Researchers
- Principal investigator: Jarvinen-Seppo, Kirsi — University of Rochester
- Study coordinator: Jarvinen-Seppo, Kirsi
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.